Angina is a medical condition characterized by chest pain or discomfort, often caused by reduced blood flow to the heart muscles. Its applications lie in the diagnosis and management of coronary artery disease, heart-related complications, and risk assessment for cardiovascular events. Features of angina include chest pain, tightness, or pressure that may radiate to the arms, neck, or jaw. Its primary use is to indicate an underlying heart problem, helping healthcare professionals determine appropriate treatments and lifestyle adjustments for patients.
According to Data Bridge Market Research, the Global Angina Market is expected to grow with a CAGR of 5.90% in the forecast period of 2022 to 2029.
“Increase in the diabetic and hypertension population boosts the market’s growth”
The angina market is experiencing growth due to an increase in the diabetic and hypertension population. Diabetes and hypertension are risk factors for developing angina, a condition characterized by chest pain and discomfort. As the prevalence of these chronic diseases rises, the number of people at risk of developing angina also increases. This drives the demand for medications and treatments to manage angina symptoms, contributing to the growth of the market for angina therapies and related healthcare services.
What restraints the growth of the Global angina market?
“Shortage of skilled healthcare professionals restraints the market’s growth”
The growth of the angina market is restrained by a shortage of skilled healthcare professionals. Angina requires specialized care and management, and a lack of trained medical personnel can lead to delays in diagnosis and treatment. Additionally, skilled professionals are essential for conducting research and clinical trials to develop new and effective treatments. The scarcity of experts in this field hampers the ability to provide optimal care to patients, potentially hindering the expansion of the angina market.
Segmentation: Global Angina Market
The global angina market is segmented on the basis of drug class, types, and end-users.
- On the basis of drug class, the angina market is segmented into beta blockers, nitrates and calcium channel blockers, angiotensin-converting enzyme inhibitors, and others.
- On the basis of types, the angina market is segmented into stable angina and unstable angina, variant (prinzmetal) angina and microvascular angina.
- On the basis of end-users, the angina market is segmented into hospitals, cardiology centers, and others.
Regional Insights: North America dominates the Global Angina Market
North America dominates the market due to factors such as well-developed healthcare sector, increasing healthcare expenditure, and a substantial patient population suffering from coronary heart diseases. These conditions create a favorable environment for the demand and adoption of angina treatments and related healthcare services, leading to the growth of the market in the region.
Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the presence of developing economies such as India and China. These countries have a rapidly developing healthcare sector that is increasing access to healthcare services and treatments for coronary heart diseases, including angina. The rising awareness about the condition and improved healthcare infrastructure are contributing to the growth of the angina market in the region.
To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/global-angina-market
The Prominent Key Players Operating in the Global Angina Market Include:
- Sanofi (France)
- Gilead Sciences, Inc. (U.S.)
- AstraZeneca (U.K.)
- Pfizer Inc. (U.S.)
- Eli Lilly and Company (U.S.)
- Amgen Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Novartis AG (Switzerland)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bristol-Myers Squibb Company (U.S.)
- Bayer AG (Germany)
- Abbott (U.S.)
- Saneron CCEL Therapeutics, Inc. (U.S.)
- Vasomedical, Inc. (U.S.)
- Cryopraxis Ltda (Brazil)
- Neovasc Inc. (Canada)
- LUMITOS AG (Germany)
Above are the key players covered in the report, to know about more and exhaustive list of global angina market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Angina Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
